Stocks and Investing Stocks and Investing
Fri, July 28, 2023

Andrew Mok Maintained (ACHC) at Strong Buy with Decreased Target to $88 on, Jul 28th, 2023


Published on 2024-10-28 05:13:24 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Maintained "Acadia Healthcare Company, Inc." (ACHC) at Strong Buy with Decreased Target from $92 to $88 on, Jul 28th, 2023.

Andrew has made no other calls on ACHC in the last 4 months.



There are 4 other peers that have a rating on ACHC. Out of the 4 peers that are also analyzing ACHC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $83 on, Wednesday, July 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Andrew


  • A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Thursday, May 4th, 2023
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, April 28th, 2023
  • Pito Chickering of "Deutsche Bank" Downgraded from Hold to Strong Sell and Decreased Target to $63 on, Thursday, April 20th, 2023
Contributing Sources